SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001571049-15-002584
Filing Date
2015-04-02
Accepted
2015-04-02 12:51:28
Documents
11
Group Members
CENTRIC CAPITAL VENTURES LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D t1500751_sc13d.htm SC 13D 65222
2 EXHIBIT 99.1 t1500751_ex99-1.htm EX-99.1 108990
3 EXHIBIT 99.2 t1500751_ex99-2.htm EX-99.2 102588
4 EXHIBIT 99.3 t1500751_ex99-3.htm EX-99.3 90723
5 EXHIBIT 99.4 t1500751_ex99-4.htm EX-99.4 110656
6 EXHIBIT 99.5 t1500751_ex99-5.htm EX-99.5 67298
7 EXHIBIT 99.6 t1500751_ex99-6.htm EX-99.6 4637
8 EXHIBIT 99.7 t1500751_ex99-7.htm EX-99.7 3756
9 GRAPHIC g49731mm05i001.gif GRAPHIC 77209
10 GRAPHIC g49731mm05i002.gif GRAPHIC 77703
11 GRAPHIC g49731mm05i003.gif GRAPHIC 20517
  Complete submission text file 0001571049-15-002584.txt   797453
Mailing Address 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address 4452 BELTWAY DRIVE ADDISON TX 75001 214-905-5145
ULURU Inc. (Subject) CIK: 0001168220 (see all company filings)

IRS No.: 412118656 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79412 | Film No.: 15746426
SIC: 2834 Pharmaceutical Preparations

Mailing Address 590 MADISON AVENUE FLOOR 18 NEW YORK NY 10022
Business Address
Sacks Bradley J. (Filed by) CIK: 0001638123 (see all company filings)

Type: SC 13D